Investments
In 2016, Altria strengthened its beer investment by supporting Anheuser-Busch InBev business combination with SABMiller. Our equity investment in AB InBev – now the largest global brewer – provides us with substantial income, cash flow and a strong asset on our balance sheet.
In 2019, Altria acquired a 45 percent equity stake in Cronos Group Inc., a leading global cannabinoid company, headquartered in Toronto, Canada.
This investment positions Altria to participate in the emerging global cannabis sector, which we believe is poised for rapid growth over the next decade. It also creates a new growth opportunity in a category that is adjacent and complementary to our core tobacco businesses.
Cronos Group will remain a Canadian publicly-traded company.